116 related articles for article (PubMed ID: 7047165)
1. Leukocyte adherence inhibition assay in human pulmonary neoplasia.
Kotlar HK; Eker P; Brennhovd I; Høst H; Høie J; Sanner T
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):141-6. PubMed ID: 7047165
[TBL] [Abstract][Full Text] [Related]
2. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
Sanner T; Kotlar HK; Eker P
Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
[TBL] [Abstract][Full Text] [Related]
3. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
4. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients.
Kotlar HK; Sanner T
Cancer Lett; 1980 Nov; 11(1):11-9. PubMed ID: 7013972
[TBL] [Abstract][Full Text] [Related]
5. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumour antigen.
Thomson DM; Tataryn DN; Schwartz R; MacFarlane JK
Eur J Cancer (1965); 1979 Sep; 15(9):1095-106. PubMed ID: 393516
[No Abstract] [Full Text] [Related]
7. Leukocyte adherence inhibition test in lung cancer immunodiagnostic detection.
Lodi M; Cavallini G; Pampolini M
Ital J Surg Sci; 1988; 18(1):25-34. PubMed ID: 2836338
[TBL] [Abstract][Full Text] [Related]
8. Humoral leukocyte adherence inhibition response in patients with oral cancer.
Becher R; Kotlar HK; Sanner T
Scand J Dent Res; 1988 Aug; 96(4):347-52. PubMed ID: 3166199
[TBL] [Abstract][Full Text] [Related]
9. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
11. Antigen specificity of squamous cancers of the head and neck based on tumor site using the slide leukocyte adherence inhibition assay.
Taylor SG; Safford PC
J Surg Oncol; 1982 May; 20(1):41-5. PubMed ID: 6176812
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
McCoy JL; Jerome LF; Anderson C; Cannon GB; Alford TC; Connor RJ; Oldham RK; Herberman RB
J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
[TBL] [Abstract][Full Text] [Related]
13. A coded study of antitumor immunity to human lung cancer assayed by tube leukocyte adherence inhibition.
Thomson DM; Ayeni RO; MacFarlane JK; Tataryn DN; Terrin M; Schraufnagel D; Wilson J; Mulder DS
Ann Thorac Surg; 1981 Apr; 31(4):314-21. PubMed ID: 6260045
[TBL] [Abstract][Full Text] [Related]
14. Specificity of micro-leucocyte adherence inhibition test in patients with gastric cancer.
Koide Y; Wakazono K; Yamagata K; Miyaji M; Yamamoto M
Gan; 1979 Aug; 70(4):541-4. PubMed ID: 92433
[TBL] [Abstract][Full Text] [Related]
15. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
16. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
17. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
18. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
Tsang PH; Roboz JP; Holland JF; Bekesi JG
Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
[TBL] [Abstract][Full Text] [Related]
19. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
[TBL] [Abstract][Full Text] [Related]
20. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]